ENDECE, LLC.

ENDECE, LLC (ENDECE) is dedicated to discovering and developing small molecules that provide an improved quality of life for patients diagnosed with debilitating disorders with few therapeutic options. ENDECE’s pipeline of products is designed to treat cancers with low five-year survival rates, neurodegenerative autoimmune diseases (e.g. MS), and pain.

Read More

Media & Press

 

 

Media & Press

Mequon company may be on the verge of CURING MS.

Read More

The Myelin Repair Foundation & Endece Neural Collaborate to Develop Myelin Regenerative Compounds for Multiple Sclerosis (MS)Treatment.

Read More

Read More